Patenton — panteon of patents

(19)

RU

(11)

2 330 649

(13)

C2

(51)

IPC

A61K31/17(2006-01-01)

A61K31/4174(2006-01-01)

A61P25/16(2006-01-01)

A61P25/28(2006-01-01)

(21) (22)

Application

2005114504/14, 2003-10-07

(24)

Start date

2003-10-07

(22)

Actual filing date

2003-10-07

(45)

Published

2008-08-10

(72)

Inventor

Viler Larri A.Dzhil Dehniehl V.Donello Dzhon E.

(73)

Holder

Allergan, Ink.

AGONISTS OF ALPHA-2B OR 2B/2C ADRENORECEPTORS FOR NEURODEGENERATIVE DISEASES TREATMENT Russian patent published in 2008 - IPC A61K31/17 A61K31/4174 A61P25/16 A61P25/28 

Abstract RU 2330649 C2

FIELD: medicine; pharmacology.

SUBSTANCE: invention concerns application of selective agonist of alpha-2B or alpha-2B/2C adrenoreceptors for manufacture of medical product (MP), applied for treatment of neurodegenerative cerebrum conditions. Applicability of selective agonist of alpha-2B or alpha-2B/2C adrenoreceptors as MP is first shown for diseases causing damaged neurons with endings approaching to black substance or moving away.

EFFECT: products have improved efficiency.

9 cl, 1 tbl, 1 ex

Similar patents RU2330649C2

Title Year Author Number
APPLICATION OF (2-IMIDAZOLIN-2-YLAMINO) QUINOXALINES IN DEMENTIA AND PARKINSON'S DISEASE TREATMENT 2003
  • Tatton Vil'Jam G.
  • Viler Larri A.
  • Dzhil Dehniehl V.
  • Donello Dzhon E.
 RU2332218C2
PHARMACEUTICAL COMPOSITIONS FOR TREATING PARKINSON'S DISEASE 2009
  • Lamensdorf Itshak
  • Sela Joram
 RU2540470C9
METHOD OF ACTIVATION OF REGULATORY T-CELLS OF ALPHA-2B ADRENERGIC RECEPTOR AGONISTS 2011
  • Dzhil Deniel V.
  • Donello Dzhon E.
  • Lurs Loren M.B.
  • Visvanat Veena
 RU2599495C2
APPLICATION OF K-252A DERIVATIVES TO TREAT DISORDERS OF PERIPHERAL OR CENTRAL NERVOUS SYSTEMS AND EXCESSIVE CYTOKINE OUTPUT 1997
  • Ehngber Tomas M.
  • Khaun Forrest A.
  • Saporito Majkl S.
  • Ehjmon Lajza D.
  • Miller Mehtt'Ju S.
  • Najt Ehrnest Ml.
 RU2183959C2
ACTIVE SOLUBLE ISOFORMS OF NEUREGULIN, WHICH CARRY POST-TRANSLATION MODIFICATIONS 2008
  • Shrattenkhol'Ts Andre
 RU2491955C2
NON-SEDATIVE A-2-AGONIST 1-(2,3-DIMETHYL-PHENYL)-ETHYL-1,3-DIHYDRO-IMIDASOLE-2-THIONE 2004
  • Chou Ken
  • Khejdelbau Tod M.
  • Donello Dzhon Eh.
  • Dzhil Dehniel V.
 RU2345987C2
SELECTIVE INVERSE SEROTONIN 2A/2C RECEPTOR AGONISTS APPLICABLES AS THERAPEUTIC AGENTS FOR NEURODEGENERATIVE DISORDERS 2008
  • Uehjner Dehvid M.
  • Dehvis Robert E.
  • Brehnn Mark R.
  • Nehsh Norman
  • Anderson Karl-Magnus A.
  • Ul'Dam Alan K.
 RU2465267C2
IMPLANT FOR PROLONGED DRUG DELIVERY 2014
  • Shia Dzhejn Guo
  • Pudzhara Chetan P.
 RU2641021C2
COMPOUNDS AND METHODS 2015
  • Li, Peng
  • Zheng, Hailin
  • Zhao, Jun
  • Wennogle, Lawrence
 RU2711442C2
SELECTIVE SEROTONIN 2A/2C RECEPTOR INVERSE AGONISTS, USED AS THERAPEUTICS FOR NEURODEGENERATIVES DISEASES 2004
  • Uehjner Dehvid M.
  • Dehvis Robert E.
  • Brehnn Mark R.
 RU2332401C2

RU 2 330 649 C2

Authors

Viler Larri A.

Dzhil Dehniehl V.

Donello Dzhon E.

Dates

2008-08-10—Published

2003-10-07—Filed

download Download PDF read Similar patents